The German pharmaceutical group said the decision from China's National Medical Products Administration hands it the first approval worldwide for a class of drugs called Factor XIa inhibitors, which ...
NIFTY50 closed the previous week with over 2.3% losses, erasing all the gains made in the week earlier. On the hourly charts, ...
U.S. Treasury yields fell in Asian trade on Monday, in the run-up to the Federal Reserve's interest-rate decision on Wednesday. Money markets have long ago priced out expectations of an interest-rate ...
Stock futures rose on Sunday evening as traders sought to shake off the S&P 500's weekly loss. S&P 500 futures were up 0.4% while Dow Jones Industrial Average futures added 154 points, or 0.3%. Nasdaq ...
The S&P 500 is nearing all-time highs, with strong earnings growth compressing forward P/E to 19x and supporting continued ...
S&P 500 companies spent a record $1.02 trillion on buybacks in the 12 months to September 2025. See the latest stock buyback ...
The article flags strong momentum (record high, breaking above ~$35.30) plus a “low AI exposure” tilt (only ~14% tech; heavy ...
Dow's longtime chief executive now has a seat at the table of a $353.6 billion bank, bringing heavy industrial and commodity-cycle experience to a lender with deep corporate credit exposure. Board ...
Time to take profits on consumer staples stocks says Scotiabank strategist Small caps to watch: Mullen Group shares soar on record results, plus updates from TransAlta, Pulse Seismic, StorageVault and ...
Hello, this is Tukasa.I will write this in advance. This draft was written on the morning of October 21st, and it was posted ...